CD8A and neoplasm: By the end of the experiment, effector CD8+ T cells were significantly reduced in the tumor (Supplemental Figure 10I) and large changes in splenic T cells were detected (Supplemental Figure 10J), with T cells that were shifted toward a naive (CD44–CD62L+) phenotype.